Proposals due Nov. 2, 2018

If you’re a therapeutics-based researcher, consider participating in Science2Startup (science2startup.com), an invitation-only symposium for biotech entrepreneurship co-organized by Atlas Venture, F-Prime Capital, Osage University Partners, and RA Capital. The goal is to build connectivity across the academic, tech transfer and venture capital communities.

This one-day symposium on April 23, 2019 in Cambridge, MA will feature presentations from top therapeutics researchers to a curated audience of experienced biotech venture capitalists, entrepreneurs at leading biotech startups and senior executives at large pharma companies. Last year, 150 venture capitalists attended the event.

Learn more and submit your proposal